Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Reply: A Review of Pharmacologic Neurostimulant Use During Rehabilitation and Recovery after Brain Injury

Reply: A Review of Pharmacologic Neurostimulant Use During Rehabilitation and Recovery after... 1052631 AOPXXX10.1177/10600280211052631Annals of PharmacotherapyKakehi and Tompkins research-article2021 Reply (to comment on previously published article) Annals of Pharmacotherapy 2022, Vol. 56(7) 861 –862 © The Author(s) 2021 Reply: A Review of Pharmacologic Article reuse guidelines: sagepub.com/journals-permissions Neurostimulant Use During Rehabilitation https://doi.org/10.1177/10600280211052631 DOI: 10.1177/10600280211052631 journals.sagepub.com/home/aop and Recovery after Brain Injury Sumie Kakehi, PharmD , 1,2 and Danielle M. Tompkins, PharmD, BCCCP First, we would like to thank the commenters for sharing or occupational therapist documentation of clinical their thoughts and insights regarding our literature review improvement in responsiveness or wakefulness) on any cal- and the use of neurostimulants after brain injury. This is an endar day within 9 days after initiating neurostimulants. exciting and rapidly evolving clinical field with the poten- Limitations of this study include the retrospective study tial for positive impact on patients’ quality of life after brain design, lack of randomization and a placebo arm, and rely- injury. The commenters shared some interesting data dis- ing upon caregiver and therapist documentation. It is note- cussing the use of amantadine after stroke. Current litera- worthy, however, that this study was performed in patients ture surrounding the use of amantadine most strongly initially treated in the ICU, as data regarding http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Pharmacotherapy SAGE

Reply: A Review of Pharmacologic Neurostimulant Use During Rehabilitation and Recovery after Brain Injury

Kakehi, Sumie; Tompkins, Danielle M.
Annals of Pharmacotherapy , Volume 56 (7): 2 – Jul 1, 2022
Download PDF
2 pages

Loading next page...
 
/lp/sage/reply-a-review-of-pharmacologic-neurostimulant-use-during-JBwyhiN5wY

References (10)

Publisher
SAGE
Copyright
© The Author(s) 2021
ISSN
1060-0280
eISSN
1542-6270
DOI
10.1177/10600280211052631
Publisher site
See Article on Publisher Site

Abstract

1052631 AOPXXX10.1177/10600280211052631Annals of PharmacotherapyKakehi and Tompkins research-article2021 Reply (to comment on previously published article) Annals of Pharmacotherapy 2022, Vol. 56(7) 861 –862 © The Author(s) 2021 Reply: A Review of Pharmacologic Article reuse guidelines: sagepub.com/journals-permissions Neurostimulant Use During Rehabilitation https://doi.org/10.1177/10600280211052631 DOI: 10.1177/10600280211052631 journals.sagepub.com/home/aop and Recovery after Brain Injury Sumie Kakehi, PharmD , 1,2 and Danielle M. Tompkins, PharmD, BCCCP First, we would like to thank the commenters for sharing or occupational therapist documentation of clinical their thoughts and insights regarding our literature review improvement in responsiveness or wakefulness) on any cal- and the use of neurostimulants after brain injury. This is an endar day within 9 days after initiating neurostimulants. exciting and rapidly evolving clinical field with the poten- Limitations of this study include the retrospective study tial for positive impact on patients’ quality of life after brain design, lack of randomization and a placebo arm, and rely- injury. The commenters shared some interesting data dis- ing upon caregiver and therapist documentation. It is note- cussing the use of amantadine after stroke. Current litera- worthy, however, that this study was performed in patients ture surrounding the use of amantadine most strongly initially treated in the ICU, as data regarding

Journal

Annals of Pharmacotherapy – SAGE

Published: Jul 1, 2022

There are no references for this article.